Abstract
Stress-induced neuroendocrine activities influence the regulation of endocrine glands and axes. Weight loss-related hypothalamic amenorrhea is a typical stress-induced physiopathological condition. It is characterized by increased adrenal cortex activation and by reduced GH, LH, FSH and gonadal steroid hormone levels. The aim of the present study was to investigate the effects of pivagabine, a neurotropic drug (1800 mg/day for 7 days) or placebo administration on ACTH, cortisol, GH, LH, FSH and PRL plasma levels in patients with hypothalamic amenorrhea related to weight loss. Hormonal parameters and the pulsatile release of cortisol (6-hour pulsatility, sampling every 10 minutes) were evaluated before and after 7 days of treatment. Pivagabine administration significantly reduced mean plasma ACTH (from 21.7±1.7 to 15.4±1.2 pg/ml, p<0.05) and cortisol levels (from 12.2±0.7 to 9.7±0.7 ng/ml, p<0.05) and increased GH levels (from 1.4±0.5 to 3.0±0.9 ng/ml, p<0.05). A significant reduction of cortisol pulse amplitude was observed (p<0.01) while no change in pulse frequency occurred. No changes were observed in placebo-treated subjects. LH, FSH and PRL levels were not modified by placebo or pivagabine administration. In conclusion, in patients with hypothalamic amenorrhea related to weight loss pivagabine induced a significant decrease of cortisol secretion and an increase of GH release by pivagabine administration, suggesting that this drug exerts a specific neuroendocrine modulatory role.
Similar content being viewed by others
References
Reifenstein E.C. Psychogenic or “hypothalamic” amenorrhea. Med. Clin. North Am. 1946, 30: 1103–1114.
Berga S.L., Mortola S.F., Girton L., Suh B., Laughlin G., Pham P., Yen S.S.C. Neuroendocrine aberrations in women with functional hypothalamic amenorrhea. J. Clin. Endocrinol. Metab. 1989, 68: 301–308.
Genazzani A.D., Gastaldi M., Volpe A., Petraglia F., Genazzani A.R. Spontaneous episodic release of adenohypophyseal hormones in hypothalamic amenorrhea. Gynecol. Endocrinol. 1995, 9: 325–334.
Genazzani A.D., Petraglia F., Volpe A., Genazzani A.R. Hypothalamic amenorrhea: neuroendocrine mechanisms/stress-induced anomalies. ARTA 1997, 9: 1–13.
Frisch R.E., McArthur J.W. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science 1974, 185: 949–951.
Ferin M. Stress and the reproductive cycle. J. Clin. Endocrinol. Metab. 1999, 84: 1768–1774.
Wildt L., Leyendecker G., Sir-Petermann T., Waibel-Treber S. Treatment with naltrexone in hypothalamic ovarian failure: induction of ovulation and pregnancy. Hum. Reprod. 1993, 8: 350–358.
Genazzani A.D., Petraglia F., Algeri I., Gastaldi M., Calvani M., Botticelli G., Genazzani A.R. Acetyl-l-carnitine as possible drug in the treatment of hypothalamic amenorrhea. Acta. Obstet. Gynecol. Scand. 1991, 70: 487–492.
Quigley M.E., Yen S.S.C. The role of endogenous opiates on LH secretion during the menstrual cycle. J. Clin. Endocr. Metab. 1980, 51: 179–181.
Petraglia F., D’Ambrogio G., Comitini G., Facchinetti F., Volpe A., Genazzani A.R. Impairment of opioid control of luteinizing hormone secretion in menstrual disorders. Fertil. Steril. 1985, 43: 535–540.
Petraglia F., Porro C., Facchinetti F., Cicoli C., Bertellini E., Volpe A., Barbieri G.C., Genazzani A.R. Opiod control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine. Life Sci. 1986, 38: 2103–2110.
Genazzani A.D., Petraglia F., Gastaldi M., Volpogni C., Gamba O., Genazzani A.R. Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea. Fertil. Steril. 1995, 64: 951–956.
Biggio G., Sanna E., Serra M., Costa E. GABAa receptors and anxiety. In: Biggio G. (Ed.), Advances in Biochemistry and Psychopharmacology. Raven press, New York, vol. 48, 1995.
Biggio G., Concas A., Corda M.G., Giorgi O., Sanna E., Serra M. GABAergic and dopaminergic transmission in the rat cerebral cortex: effect of stress, anxiolytic and anxiogenic drugs. Pharmacol. Ther. 1990, 48: 121–142.
Concas A., Serra M., Atsoggiu T., Biggio G. Foot shock and anxiogenic beta-carbolines increase t-[35S]- butylbicyclophosphorotionate binding in the rat cerebral cortex, an effect opposite to anxiolytic and gamma-aminobutyric acid mimetics. J. Neurochem. 1988, 51: 1868–1876.
Kalogeras K.T., Calogero A.E., Kuribayiashi T., Khan I., Gallucci W.T., Kling M.A., Chrousos G.P., Gold P.W. In vitro and in vivo effects of the triazolobenzodiazepine alprazolam and hypothalamic-pituitaryadrenal function: pharmacological and clinical implications. J. Clin. Endocrinol. Metab. 1990, 70: 1462–1471.
Imaki T., Vale W. Chlordiazepoxide attenuates stress-induced accumulation of corticotropin-releasing factor mRNA in the paraventricular nucleus. Brain Res. 1993, 623: 223–228.
Imaki T., Xiao-Quan W., Shibasaki T., Harada S., Chikada N., Takahashi C., Naruse M., Demura H. Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF) gene trascription and CRF biosynthesis in the paraventricular necleus (PVN). Mol. Brain Res. 1995, 32: 261–270.
Galzigna L., Garbin L., Bianchi M., Marzotto A. Properties of two derivatives of gamma-aminobutyric acid (GABA) capable of abolishing Cardiazol- and bicuculline-induced convulsions in the rat. Arch. Int. Pharmacodyn. Ther. 1978, 235: 73–85.
Esposito G., Luparini M.R. Pivagabine: a novel psychoactive drug. Arzneim Forsch Drug Res. 1997, 47: 1306–1309.
Serra M., Concas A., Mostallino M.C., Chessa M.F., Stomati M., Petraglia F., Genazzani A.R., Biggio G. Antagonism by pivagabine of stress-induced changes in GABA a receptor function and corticotropin-releasing factor concentrations in rat brain. Psychoneuroendocrinology 1999, 24: 269–284.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC, American Psychiatric Association, 1995.
Genazzani A.D., Massolo F., Ferrari E., Gandolfi A., Petraglia F., Genazzani A.R. Long-term GnRH agonist administration revealed a GnRH independent mechanism stimulating FSH discharge in humans. Eur. J. Endocrinol. 1996, 134: 77–83.
Genazzani A.D., Rodbard D. Evaluation of methods for detection of pulsatile hormone secretion: sensitivity vs. specificity. Acta Endocrinol. (Copenh.) 1991, 124: 295–306.
Oerter K.E., Guardabasso V. and Rodbard D. Detection and characterization of peaks and estimation of instantaneous secretory rate for episodic pulsatile hormone secretion. Comput. Biom. Res. 1986, 19: 170–191.
Cameron J.L. Regulation of reproductive hormone secretion in primates by short-term changes in nutrition. Rev. Reprod. 1996, 1: 117–126.
Scapagnini U., Matera M. Effects of pivagabine on psychophysical performance and behavioural response in experimental models of stress. Arzneim Forsch Drug Res. 1997, 47: 1310–1317.
Gigliotti B., Multinu A., Lai V.R. Role of pivagabine in the treatment of climacteric syndrome. Arzneim Forsch Drug Res. 1997, 47: 1317–1321.
Genazzani A.D., Petraglia F., Volpogni C., Gastaldi M., Pianazzi F., Montanini V., Genazzani A.R. Modulatory role of estrogens and progestins on growth hormone episodic release in women with hypothalamic amenorrhea. Fertil. Steril. 1993, 60: 465–470.
Nappi R.E., Petraglia F., D’Ambrogio G., Zara C., Genazzani A.R. Hypothalamic amenorrhea: evidence of a central derangement of hypothalamic-pituitary-adrenal cortex axis activity. Fertil. Steril. 1993, 59: 571–576.
Britton K.T., Lee G., Koob G.F. Corticotropin releasing factor and amphetamine exaggerate partial agonist properties of benzodiazepine antagonist Ro 15-1788 in the conflict test. Psychopharmacology 1988, 94: 306–31132.
De Boer S.F., Slanger J.L., Van de Gutner J. Brain benzodiazepine receptor control of stress hormones. In: Kvetnasky R., Mc Carty R., Axelrod J. (Eds), Stress, neuroendocrine and molecular approaches. Gordon and Breanch, Philadelphia, 1995, 719–734.
Owens M.J., Bissette G., Nemeroff C.B. Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain. Synapse 1989, 4: 196–202.
Barbarino A., Corsello S.M., Della Casa S., Tofani A., Sciuto R., Rota C.A., Bollanti L., Barini A. Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man. J. Clin. Endocrinol. Metab. 1990, 71: 1368–1374.
Robel P., Baulieu E.E. Neurosteroids: biosynthesis and function. TEM 1994, 5: 1–8.
Purdy R.H., Morow A.L., Moore P.H. Jr., Paul S.M. Stress-induced elevation of ?-aminobutyric acid type A receptor-active steroids in the rat brain. Proc. Natl. Acad. Sci. USA 1991, 88: 4553–4557.
Facchinetti F., Fava M., Fioroni L., Genazzani A.D., Genazzani A.R. Stressful life events and affective disorders inhibit pulsatile LH secretion in hypothalamic amenorrhea. Psychoneuroendocrinology 1993, 18: 397–404.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Genazzani, A.D., Stomati, M., Bersi, C. et al. Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea. J Endocrinol Invest 23, 526–532 (2000). https://doi.org/10.1007/BF03343769
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343769